When in combination with liver-specific IL-12 or IL-7, OXP increased CD8+/ Treg cell ratio in murine metastatic colon cancer model, reducing immune suppressive response and further enhancing anti-tumor immune response [32–35]. Here, IL7 is linked to neoplasm.